SGRY(Surgery Partners, Inc.) 的财务报表:医疗保健,医疗机构。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $2.23B | $2.54B | $2.74B | $3.11B | $3.31B |
| 毛利润 | — | — | — | — | — |
| 营业利润 | $302.20M | $345.20M | $328.00M | $348.80M | $389.50M |
| 净利润 | −$70.90M | −$54.60M | −$11.90M | −$168.10M | −$77.90M |
| 经营现金流 | $87.10M | $158.80M | $293.80M | $300.10M | $274.30M |
| 自由现金流 | $29.50M | $78.20M | $205.00M | $209.70M | $195.60M |
| 摊薄每股收益 | $-1.12 | $-0.59 | $-0.09 | $-1.33 | $-0.61 |